Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox at Time of HoLEP in Men With OAB Symptoms
NCT05878951Phase 3Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Jul 2023
- Primary completion
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Northwestern University. Started Jul 2023; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT05878951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05878951.